BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $621 | -$15,838 | -$448 | $12,459 |
| Dep. & Amort. | $1,335 | $1,382 | $1,384 | $1,704 |
| Deferred Tax | $14 | $45 | $6 | $24 |
| Stock-Based Comp. | $5,904 | $5,859 | $4,153 | $10,692 |
| Change in WC | $3,677 | $85 | -$3,762 | $1,123 |
| Other Non-Cash | -$5,447 | $15,835 | $394 | -$24,357 |
| Operating Cash Flow | $6,104 | $7,368 | $1,727 | $1,645 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,302 | -$1,743 | -$175 | -$762 |
| Net Acquisitions | $0 | $0 | $0 | $73,431 |
| Inv. Purchases | -$13,090 | -$33,979 | -$30,324 | -$2,441 |
| Inv. Sales/Matur. | $12,568 | $6,267 | $3,573 | $3,709 |
| Other Inv. Act. | -$2,143 | -$10,078 | -$250 | -$300 |
| Investing Cash Flow | -$5,967 | -$39,533 | -$27,176 | $73,637 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$2,500 | -$2,500 | -$3,426 |
| Stock Issued | -$18 | $18 | $0 | $65 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,870 | -$396 | -$492 | -$725 |
| Financing Cash Flow | $5,870 | -$2,878 | -$2,992 | -$4,086 |
| Forex Effect | $0 | $0 | $0 | $29 |
| Net Chg. in Cash | $0 | -$35,043 | -$28,441 | $71,225 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31,902 | $66,945 | $95,386 | $24,161 |
| End Cash | $0 | $31,902 | $66,945 | $95,386 |
| Free Cash Flow | $2,802 | $5,625 | $1,552 | $583 |